Study identifier:D3560C00004
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Randomized, Double-Blind, multicenter, trial to assess the effect of high and Low doses of ZD4522 on progression of Carotid Artery Atheroma in moderately Hypercholesterolemic subjects with Asymptomatic Carotid Stenosis after 24 months of dosing.
hypercholesterolaemia
Phase 3
-
-
-
-
Interventional
-
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Feb 2015 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|